Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2047-2054

  Huang, Mingjun ^a,b   Zensen, Ralf ^a   Cho, Michael ^a   Martin, Malcolm A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE;

AMINO ACID SUBSTITUTION; ARTICLE; ENZYME ACTIVITY; GENE MUTATION; PRIORITY JOURNAL; PROGENY; QUANTITATIVE DIAGNOSIS; RADIOIMMUNOPRECIPITATION; SITE DIRECTED MUTAGENESIS; TEMPERATURE SENSITIVITY; VIRION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0031912656     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2047-2054.1998     Document Type: Article

References (56)

1. Bass, S. H., M. G. Mulkerrin, and J. A. Well. 1991. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl. Acad. Sci. USA 88:4498-4502.
2. Beard, W. A., S. J. Stahl, H. R. Kim, K. Bebenek, A. Kumar, M. P. Strub, S. P. Becerra, T. A. Kunkel, and S. H. Wilson. 1914. Structure/function studies of human immunodeficiency virus type 1 reverse transcriptase. Alanine scanning mutagenesis of an alpha-helix in the thumb subdomain. J. Biol. Chem. 269:28091-28097.
3. Beard, W. A., and S. H. Wilson. 1994. Site-directed mutagenesis of HIV reverse transcriptase to probe enzyme processivity and drug binding. Curr. Opin. Biotechnol. 5:414-421.
4. Beard, W. A., D. T. Minnick, C. L. Wade, R. Prasad, R. L. Won, A. Kumar, T. A. Kunkel, and S. A. Wilson. 1996. Role of the helix clamp in HIV-1 reverse transcriptase catalytic cycling as revealed by alanine-scanning mutagenesis. J. Biol. Chem. 271:12213-12220.
5. Boyer, P. L., A. I. Ferris, and S. H. Hughes. 1992. Cassette mutagenesis of the reverse transcriptase of human immunodeficiency virus type 1. J. Virol. 66:1031-1039.
6. Boyer, P. L., A. L. Ferris, and S. H. Hughes. 1992. Mutational analysis of the fingers domain of human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 66:7533-7537.
7. Boyer, P. L., A. I. Ferris, P. Clark, J. Whitmer, P. Frank, C. Tantillo, E. Arnold, and S. H. Hughes. 1994. Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase. J. Mol. Biol. 243:472-483.
8. Boyer, P. L., C. Tantillo, A. Jacobo-Molina, R. G. Nanni, J. Ding, E. Arnold, and S. H. Hughes. 1994. Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc. Natl. Acad. Sci. USA 91:4882-4886.
9. Chao, S.-F., V. L. Chan, P. Juranka, A. H. Kaplan, R. Swanstrom, and C. A. Hutchison III. 1995. Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1. Nucleic Acids Res. 23:803-810.
10. Clark, P. K., A. L. Ferris, D. A. Miller, A. Hizi, K. W. Kim, S. M. Deringer-Boyer, M. L. Mellini, A. D. Clark, G. F. Atnold, and W. B. Lebherz III. 1990. HIV-1 reverse transcriptase purified from a recombinant strain of E. coli. AIDS Res. Hum. Retroviruses 6:753-764.
11. DeClerq, E. 1994. HIV resistance to reverse transcriptase inhibitors. Biochem. Pharmacol. 47:155-169.
12. Diamond, S. E., and K. Kirkegaard. 1994. Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature-sensitive mutants defective in RNA synthesis. J. Virol. 68:863-876.
13. di Marzo Veronese, F., T. D. Copeland, A. L. DeVico, R. Rahman, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1986. Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV. Science 231:1289-1291.
14. Freed, E. O., and M. A. Martin. 1994. Evidence for a functional interaction between the V1/V2 and CD4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120. J. Virol. 68:2503-2512.
15. Gao, Q., Z. Gu, M. A. Parniak, J. Cameron, N. Cammack, C. Boucher, and M. A. Wainberg. 1993. The same mutation that encodes low-level human immunodeficiency virus type 1 resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine confers high-level resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine. Antimicrob. Agents Chemother. 37:1390-1392.
16. Ghosh, M., P. S. Jacques, D. W. Rodgers, M. Ottman, J.-L. Darlix, and S. F. J. Le Grice. 1996. Alternations to the primer grip of p66 HIV-1 reverse transcriptase and their consequences for template-primer utilization. Biochemistry 35:8553-8562.
17. Gu, Z., Q. Gao, H. Fang, H. Salomon, M. A. Parniak, E. Goldberg, J. Cameron, and M. A. Wainberg. 1994. Identification of a mutation at codon 65 in the IKKK motif of reverse transcriptase that encodes human immunodeficiency virus resistance to 2′,3′-dideoxycytidine and 2′,3′-dideoxy-3′-thiacytine. Antimicrob. Agents Chemother. 38:275-281.
18. Gu, Z., R. S. Fletcher, E. J. Arts, M. A. Wainberg, and M. A. Parniak. 1994. The K65R mutant reverse transcriptase of HIV-1 cross-resistant to 2′,3′-dideoxycytidine, 2′,3′-dideoxy-3′-thiacytine, and 2′,3′-dideoxyinosine shows reduced sensitivity to specific dideoxynucleoside triphosphate inhibitors in vitro. J. Biol. Chem. 269:28118-28122.
19. Hassett, D. E., and R. C. Condit. 1994. Targeted construction of temperature-sensitive mutations in vaccinia virus by replacing clustered charged residues with alanine. Proc. Natl. Acad. Sci. USA 91:4554-4558.
20. Hizi, A., C. McGill, and S. H. Hughes. 1988. Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in E. coli and analysis of mutants. Proc. Natl. Acad. Sci. USA 85:1218-1222.
21. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69:6810-6818.
22. Jacobo-Molina, A., and E. Arnold. 1991. HIV reverse transcriptase structure-function relationship. Biochemistry 30:6351-6361.
23. Jacobo-Molina, A., J. Ding, R. G. Nanni, A. D. Clark, Jr., X. Lu, C. Tantillo, R. L. Williams, G. Kamer, A. L. Ferris, P. Clark, A. Hizi, S. H. Hughes, and E. Arnold. 1993. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc. Natl. Acad. Sci. USA 90:6320-6324.
24. Jacques P. S., B. M. Wohrt, M. Ottmann, J. L. Darlix, and S. F. J. Le Grice. 1994. Mutating the "primer grip" of p66 HIV-1 reverse transcriptase implicates tryptophan-229 in template-primer utilization. J. Biol. Chem. 269: 26472-26478.
25. Kaplan, A. H., M. Manchester, and R. Swanstrom. 1994. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68:6782-6786.
26. Kim, B., T. R. Hathaway, and L. A. Loeb. 1996. Human immunodeficiency virus reverse transcriptase. Functional mutants obtained by random mutagenesis coupled with genetic selection in Escherichia coli. J. Biol. Chem. 271:4872-4878.
27. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239
28. Kohlstaedt, L. A., J. Wang, J. M. Friesman, P. A. Rice, and T. A. Steitz. 1992. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complex with an inhibitor. Science 256:1783-1790.
29. Kunkel, T. A., J. D. Roberts, and R. A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
30. Larder, B., D. Purifor, K. Powell, and G. Darby. 1987. AIDS virus reverse transcriptase defined by high level expression in E. coli. EMBO J. 6:3133-3137.
31. Larder, B., D. Purifor, K. Powell, and G. Darby. 1987. Site-specific mutagenesis of AIDS virus reverse transcriptase. Nature (London) 327:716-717.
32. Larder, B. A. 1995. Viral resistance and the selection of antiviral combinations. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10(Suppl. 1):S28-S33.
33. Larder, B. A., S. D. Kemp, and D. Purifor. 1989. Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity. Proc. Natl. Acad. Sci. USA 86:4803-4807.
34. Le Grice, S. F. J., T. Naas, B. Wohlgensinger, and O. Schatz. 1991. Subunit-selective mutagenesis indicates minimal polymerase activity in heterodimer-associated p51 HIV-1 reverse transcriptase. EMBO J. 10:3905-3911.
35. Loeb, D. D., R. Swanstrom, L. Everitt, M. Manchester, S. E. Stamper, and C. A. Hutchison III. 1989. Complete mutagenesis of the HIV-1 protease. Nature (London) 340:391-400.
36. Lowe D. M., A. Aitken, C. Bradley, G. K. Darby, B. A. Larder, K. L. Powell, D. J. Purifoy, M. Tisdale, and D. K. Stammers. 1988. HIV-1 reverse transcriptase: crystallization and analysis of domain structure by limited proteolysis. Biochemistry 27:8884-8889.
37. Lowe, D. M., V. Parmor, S. D. Kemp, and B. A. Larder. 1991. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase. FEBS Lett. 282:231-234.
38. Muller B., T. Restle, S. Weiss, M. Gautel, G. Sczakiel, and R. S. Goody. 1989. Co-expression of the subunits of the heterodimer of HIV-1 reverse transcriptase in Escherichia coli. J. Biol. Chem. 264:13975-13978.
39. IIIB with reduced replication phenotypes. J. Virol. 70:3698-3705.
40. gag and is incorporated into viruslike particles. J. Virol. 66:6304-6313.
41. Peden, K., M. Emerman, and L. Montagnier. 1991. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1 LAI, HIV-1 MAL, and HIV-1 ELI. Virology 185:661-672.
42. Restle, T., B. Muller, and R. S. Goody. 1990. Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J. Biol. Chem. 265:8986-8988.
43. Richman, D. D. 1993. Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents. Antimicrob. Agents Chemother. 37: 1207-1213.
44. Rodgers D. W., S. J. Gamblin, B. A. Harris, S. Ray, J. S. Culp, B. Hellmig, D. J. Woolf, C. Debouck, and S. C. Harrison. 1995. The structure of unligated reverse transcriptase from human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:1222-1226.
45. Ross E. K., A. J. Buckler-White, A. B. Rabson, G. England, and M. A. Martin. 1991. Contribution of NF-κB and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types. J. Virol. 65:4350-1358.
46. Rowley, G. L., Q. F. Ma, I. C. Bathurst, P. J. Barr, and G. L. Kenyon. 1990. Stabilization and activation of recombinant human immunodeficiency virus-1 reverse transcriptase-P66. Biochem. Biophys. Res. Commun. 167:673-679.
47. gag-pol from human immunodeficiency virus type 1 into virus-like particles. J. Virol. 67:2266-2275.
48. Tanese, N., V. R. Prasad, and S. P. Goff. 1988. Structural requirements for bacterial expression of stable, enzymatically active fusion proteins containing the human immunodeficiency virus reverse transcriptase. DNA 7:407-416.
49. Wang, J., S. J. Smerdon, J. Jager, L. A. Kohlstaedt, P. A. Rice, J. M. Friedman, and T. A. Steitz. 1994. Structural basis of asymmetry in the human immunodeficiency virus type 1 reverse transcriptase heterodimer. Proc. Natl. Acad. Sci. USA 91:7242-7246.
50. Wertman, K. F., D. G. Drubin, and D. Botstein. 1992. Systematic mutational analysis of yeast ACT1 gene. Genetics 132:337-350.
51. Willey, R. L., D. H. Smith, L. A. Lasky, T. S. Theodore, P. L. Earl, B. Moss, D. J. Capon, and M. A. Martin. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:139-147.
52. Willey, R. L., J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner. 1988. Biosynthesis, cleavage and degradation of the human immunodeficiency virus type 1 envelope glycoprotein gp160. Proc. Natl. Acad. Sci. USA 85:9580-9584.
53. Willey, R. L., T. Klimkait, D. M. Frucht, J. S. Bonifacino, and M. A. Martin. 1991. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology 184:319-329.
54. Wills, J., and R. C. Craven. 1991. Form, function, and use of retroviral gag proteins. AIDS 5:639-654. (Editorial.)
55. Wiskerchen, M., and M. A. Muesing. 1995. Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene. J. Virol. 69:597-601.
56. Zhang, D., A. M. Caliendo, J. J. Eron, K. M. DeVore, J. C. Kaplon, M. S. Hirsch, and R. T. D'Aquila. 1994. Resistance to 2′,3′-dideoxycytidine conferred by a mutation in codon 65 of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob. Agents Chemother. 38:282-287.